Renaissance Technologies Portfolio holdings
Renaissance Technologies LLC, founded in 1982 by mathematician James Simons as Monemetrics and headquartered in East Setauket, New York, is a legendary quantitative hedge fund managing around $65 billion in assets as of late 2024, renowned for its pioneering use of mathematical models and algorithms in trading. Starting with currency trading and evolving into a secretive powerhouse under its flagship Medallion Fund—launched in 1988—the firm employs PhDs, physicists, and computer scientists to analyze vast datasets, executing high-frequency trades across equities, futures, and derivatives with returns averaging over 66% annually before fees from 1988 to 2018. Simons, who stepped down as chairman in 2021, built a culture of intellectual rigor, limiting Medallion to employees and insiders since 1993 while offering institutional funds like the Renaissance Institutional Equities Fund (RIEF) to outsiders. Now led by Peter Brown and Robert Mercer’s successors, Renaissance remains a benchmark for quant investing, blending academic precision with a low-profile, extraordinarily profitable legacy despite occasional regulatory scrutiny.
Top Buys
| 1 |
Zoom
ZM
|
+$406M |
| 2 |
Baidu
BIDU
|
+$382M |
| 3 |
AGN
Allergan plc
AGN
|
+$366M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$322M |
| 5 |
NextEra Energy, Inc.
NEE
|
+$312M |
Top Sells
| 1 |
Tesla
TSLA
|
+$1.66B |
| 2 |
Meta Platforms (Facebook)
META
|
+$370M |
| 3 |
Pfizer
PFE
|
+$343M |
| 4 |
Gilead Sciences
GILD
|
+$331M |
| 5 |
Amazon
AMZN
|
+$282M |
Sector Composition
| 1 | Healthcare | 25.43% |
| 2 | Technology | 12.73% |
| 3 | Consumer Staples | 9.8% |
| 4 | Financials | 8.2% |
| 5 | Utilities | 8.06% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
3201
Atlantic American Corp
AAME
$66.2M
| $114K | ﹤0.01% |
54,000
| – | – |
|
|
JG
3202
Aurora Mobile
JG
$60.1M
| $114K | ﹤0.01% |
2,481
+475
| +24% | +$21.8K |
|
|
SSY
3203
DELISTED
SunLink Health Systems
SSY
| $114K | ﹤0.01% |
167,400
+8,700
| +5% | +$5.93K |
|
3204
Smart Powerr
CREG
$4.88M
| $113K | ﹤0.01% |
3,497
-913
| -21% | -$29.5K |
|
3205
Tidewater
TDW
$2.97B
| $113K | ﹤0.01% |
+16,000
| New | +$113K |
|
|
NMTR
3206
DELISTED
9 Meters Biopharma, Inc. Common Stock
NMTR
| $113K | ﹤0.01% |
11,270
+7,765
| +222% | +$77.9K |
|
|
TRMT
3207
DELISTED
Tremont Mortgage Trust Common Shares of Beneficial Interest
TRMT
| $111K | ﹤0.01% |
52,946
-16,674
| -24% | -$35K |
|
|
UNAM
3208
DELISTED
Unico American Corp
UNAM
| $110K | ﹤0.01% |
21,800
+1,200
| +6% | +$6.06K |
|
|
CCRC
3209
DELISTED
China Customer Relations Centers, Inc
CCRC
| $110K | ﹤0.01% |
24,306
+2,100
| +9% | +$9.5K |
|
3210
Cogent Biosciences
COGT
$1.78B
| $109K | ﹤0.01% |
65,901
-22,714
| -26% | -$37.6K |
|
3211
Jerash Holdings
JRSH
$44.1M
| $109K | ﹤0.01% |
21,484
-404
| -2% | -$2.05K |
|
3212
Pioneer Bancorp
PBFS
$337M
| $108K | ﹤0.01% |
+10,400
| New | +$108K |
|
3213
SuperCom
SPCB
$42M
| $108K | ﹤0.01% |
587
+253
| +76% | +$46.5K |
|
|
CORV
3214
DELISTED
Correvio Pharma Corp. Ordinary Shares (Canada)
CORV
| $108K | ﹤0.01% |
278,400
+37,686
| +16% | +$14.6K |
|
3215
Accel Entertainment
ACEL
$935M
| $107K | ﹤0.01% |
+14,200
| New | +$107K |
|
3216
Caledonia Mining Corp
CMCL
$597M
| $107K | ﹤0.01% |
11,500
-3,156
| -22% | -$29.4K |
|
3217
Dominari Holdings
DOMH
$103M
| $107K | ﹤0.01% |
12,398
+8,858
| +250% | +$76.4K |
|
|
YVR
3218
DELISTED
Liquid Media Group Ltd. Common Shares
YVR
| $106K | ﹤0.01% |
+9,633
| New | +$106K |
|
3219
Mind CTI
MNDO
$24.5M
| $105K | ﹤0.01% |
60,500
-41,432
| -41% | -$71.9K |
|
|
ENFY
3220
Enlightify Inc.
ENFY
$16.4M
| $105K | ﹤0.01% |
40,476
-15,801
| -28% | -$41K |
|
|
SANW
3221
DELISTED
S&W Seed Co
SANW
| $104K | ﹤0.01% |
2,657
-27
| -1% | -$1.06K |
|
|
EVLO
3222
DELISTED
Evelo Biosciences, Inc. Common Stock
EVLO
| $104K | ﹤0.01% |
1,379
-81
| -6% | -$6.11K |
|
3223
LoveSac
LOVE
$302M
| $103K | ﹤0.01% |
+17,676
| New | +$103K |
|
|
AMRB
3224
DELISTED
American River Bankshares
AMRB
| $103K | ﹤0.01% |
11,900
-5,402
| -31% | -$46.8K |
|
3225
Stereotaxis
STXS
$256M
| $102K | ﹤0.01% |
33,788
-86,300
| -72% | -$261K |
|